648TiP Reduction of methotrexate (MTX) levels after glucarpidase in patients with diffuse large b cell lymphoma (DLBCL) at risk of central nervous system (CNS) involvement who receive cycles of HDMTX: An open-label, interventional, non-randomized, phase II, pilot, multicenter study
| Autor: | de la Fuente Burguera, A., Peñalver Parraga, F.J., Cordoba Mascunano, R., Herrera, P., Olave, M.T., Martiniez Chamorro, C., Jarque, I., Estevez Fernandez, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S837-S837 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|